DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. August 13, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. August 13, 2010 Zheng (Rita) Liu Chief Financial Officer]

DHRM [Dehaier Medical Systems] 10-Q:

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. August 13, 2010 Ping Chen Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. August 13, 2010 Zheng (Rita) Liu Chief Financial Officer]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China — August 9, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June 30, 2010. Highlights for Second Quarter and First Half 2010 — Net revenues were]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. May 14, 2010 Ping Chen Chief Executive Officer EX-32.1 4 dex321.htm SECTION 906 CEO CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. May 14, 2010 Zheng (Rita) Liu Chief Financial Officer EX-32.2 5 dex322.htm SECTION 906 CFO CERTIFICATION]

DHRM [Dehaier Medical Systems] 10-Q:

[] [CERTIFICATION I, Ping Chen, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Quarterly Report on Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. May 14, 2010 Ping Chen Chief Executive Officer EX-32.1 4 dex321.htm SECTION 906 CEO CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the condensed consolidated financial condition and results of operations of the Company. May 14, 2010 Zheng (Rita) Liu Chief Financial Officer EX-32.2 5 dex322.htm SECTION 906 CFO CERTIFICATION]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China — May 10, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March 31, 2010. Highlights for First Quarter 2010 – Net revenues were $145.8 million, an increase of 8.7%]

Skip to toolbar